TNF-α induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin

  • Daniel Chappell
  • Klaus Hofmann-Kiefer
  • Matthias Jacob
  • Markus Rehm
  • Josef Briegel
  • Ulrich Welsch
  • Peter Conzen
  • Bernhard F. Becker



Healthy vascular endothelium is clothed by the endothelial glycocalyx. This structure plays a key role in the regulation of inflammation and vascular permeability and is known to be degraded by ischemic and inflammatory stress. Our aim was to show whether hydrocortisone and antithrombin stabilize the glycocalyx and, therefore, the vascular barrier, against damage induced by the inflammatory stimulus TNF-α, thus improving the cardio-vascular situation.


Isolated guinea pig hearts were perfused with Krebs–Henseleit buffer for 20 min at constant flow (baseline perfusion pressure 70 cmH2O). Hydrocortisone in a stress dose (10 µg/ml) or antithrombin in a physiological dose (1 U/ml) were then applied for 15 min before infusion of TNF-α (4 ng/ml, 10 min). Coronary net fluid filtration was assessed directly by measuring transudate formation on the epicardial surface. Hearts were perfusion-fixed to visualize the glycocalyx.


TNF-α induced severe degradation of the glycocalyx, increased coronary resistance, heightened vascular leak and permeability to hydroxyethyl starch and caused mast-cell degranulation. Hydrocortisone and antithrombin both reduced all of these effects. Electron microscopy revealed a mostly intact glycocalyx after treatment with either drug.


Both hydrocortisone and antithrombin clearly preserve the endothelial glycocalyx in the face of inflammatory degradation initiated by TNF-α, however, with different mechanisms. This is an important new facet in the pathophysiology and therapy of sepsis, since preservation of the glycocalyx should help prevent vasoconstriction, tissue edema as well as leukocyte and platelet adhesion, thus mitigating inflammation and tissue hypoxia.


TNF-α glycocalyx endothelium hydrocortisone antithrombin 



The study was performed using departmental resources and a competitive grant of the Friedrich Baur Foundation (0027/2007) of the Ludwig-Maximilians University, Munich, Germany.

Conflict of interest None of the authors have any conflicts of interest in connection with this work.


  1. 1.
    Annane D (2005) Glucocorticoids in the treatment of severe sepsis and septic shock. Curr Opin Crit Care 11:449–453PubMedCrossRefGoogle Scholar
  2. 2.
    Bar-Ner M, Eldor A, Wasserman L, Matzner Y, Cohen IR, Fuks Z, Vlodavsky I (1987) Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species. Blood 70:551–557PubMedGoogle Scholar
  3. 3.
    Baudo F, de CF (2000) Antithrombin III concentrates in the treatment of sepsis and septic shock: indictions, limits and future prospects. Minerva Anestesiol 66:3–23PubMedGoogle Scholar
  4. 4.
    Becker BF (1993) Towards the physiological function of uric acid. Free Radic Biol Med 14:615–631PubMedCrossRefGoogle Scholar
  5. 5.
    Bose D, Leineweber K, Konorza T, Zahn A, Brocker-Preuss M, Mann K, Haude M, Erbel R, Heusch G (2007) Release of TNF-alpha during stent implantation into saphenous vein aortocoronary bypass grafts and its relation to plaque extrusion and restenosis. Am J Physiol Heart Circ Physiol 292:H2295–H2299PubMedCrossRefGoogle Scholar
  6. 6.
    Boyer A, Chadda K, Salah A, Annane D (2006) Glucocorticoid treatment in patients with septic shock: effects on vasopressor use and mortality. Int J Clin Pharmacol Ther 44:309–318PubMedGoogle Scholar
  7. 7.
    Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, Treacher DF (2006) Neutrophils in development of multiple organ failure in sepsis. Lancet 368:157–169PubMedCrossRefGoogle Scholar
  8. 8.
    Chappell D, Jacob M, Hofmann-Kiefer K, Bruegger D, Rehm M, Conzen P, Welsch U, Becker BF (2007) Hydrocortison prevserves the vascular barrier by protecting the endothelial glycocalyx. Anesthesiology 107:776–784PubMedGoogle Scholar
  9. 9.
    Chappell D, Jacob M, Rehm M, Stoeckelhuber M, Welsch U, Conzen P, Becker BF (2008) Heparinase selectively sheds heparan sulphate from the endothelial glycocalyx. Biol Chem 389:79–82PubMedCrossRefGoogle Scholar
  10. 10.
    Constantinescu AA, Vink H, Spaan JA (2003) Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface. Arterioscler Thromb Vasc Biol 23:1541–1547PubMedCrossRefGoogle Scholar
  11. 11.
    Czarnowska E, Karwatowska-Prokopczuk E (1995) Ultrastructural demonstration of endothelial glycocalyx disruption in the reperfused rat heart. Involvement of oxygen free radicals. Basic Res Cardiol 90:357–364PubMedCrossRefGoogle Scholar
  12. 12.
    Fert-Bober J, Leon H, Sawicka J, Basran RS, Devon RM, Schulz R, Sawicki G (2008) Inhibiting matrix metalloproteinase-2 reduces protein release into coronary effluent from isolated rat hearts during ischemia-reperfusion. Basic Res Cardiol 103:431–443Google Scholar
  13. 13.
    Forster C, Burek M, Romero IA, Weksler B, Couraud PO, Drenckhahn D (2008) Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier. J Physiol 586:1937–1949PubMedCrossRefGoogle Scholar
  14. 14.
    Forster H, Wicarkzyk C, Dudziak R (1981) Determination of the plasma elimination of hydroxyethyl starch and dextran using improved analytical methods. Infusionsther Klin Ernahr 8:88–94PubMedGoogle Scholar
  15. 15.
    Gando S, Nanzaki S, Sasaki S, Aoi K, Kemmotsu O (1998) Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock. Crit Care Med 26:2005–2009PubMedCrossRefGoogle Scholar
  16. 16.
    Gao X, Belmadani S, Picchi A, Xu X, Potter BJ, Tewari-Singh N, Capobianco S, Chilian WM, Zhang C (2007) Tumor necrosis factor-alpha induces endothelial dysfunction in Lepr(db) mice. Circulation 115:245–254PubMedCrossRefGoogle Scholar
  17. 17.
    Gilles S, Zahler S, Welsch U, Sommerhoff CP, Becker BF (2003) Release of TNF-alpha during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers. Cardiovasc Res 60:608–616PubMedCrossRefGoogle Scholar
  18. 18.
    Gotz AK, Zahler S, Stumpf P, Welsch U, Becker BF (2005) Intracoronary formation and retention of micro aggregates of leukocytes and platelets contribute to postischemic myocardial dysfunction. Basic Res Cardiol 100:413–421PubMedCrossRefGoogle Scholar
  19. 19.
    Grunfeld JP, Eloy L (1987) Glucocorticoids modulate vascular reactivity in the rat. Hypertension 10:608–618PubMedGoogle Scholar
  20. 20.
    Hafezi-Moghadam A, Simoncini T, Yang Z, Limbourg FP, Plumier JC, Rebsamen MC, Hsieh CM, Chui DS, Thomas KL, Prorock AJ, Laubach VE, Moskowitz MA, French BA, Ley K, Liao JK (2002) Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med 8:473–479PubMedCrossRefGoogle Scholar
  21. 21.
    Harada N, Okajima K, Kushimoto S, Isobe H, Tanaka K (1999) Antithrombin reduces ischemia/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin. Blood 93:157–164PubMedGoogle Scholar
  22. 22.
    Henry CB, Duling BR (2000) TNF-alpha increases entry of macromolecules into luminal endothelial cell glycocalyx. Am J Physiol Heart Circ Physiol 279:H2815-H2823PubMedGoogle Scholar
  23. 23.
    Jacob M, Bruegger D, Rehm M, Stoeckelhuber M, Welsch U, Conzen P, Becker BF (2007) The endothelial glycocalyx affords compatibility of Starling’s principle and high cardiac interstitial albumin levels. Cardiovasc Res 73:575–586PubMedCrossRefGoogle Scholar
  24. 24.
    Jacob M, Rehm M, Loetsch M, Paul JO, Bruegger D, Welsch U, Conzen P, Becker BF (2007) The endothelial glycocalyx prefers albumin for evoking shear stress-induced, nitric oxide-mediated coronary dilatation. J Vasc Res 44:435–443PubMedCrossRefGoogle Scholar
  25. 25.
    Kapilevich LV, Anfinogenova YD, Nosarev AV, Baskakov MB, Kovalev IV, D’yakova EY, Medvedev MA (2001) Histaminergic regulation of smooth muscles in rabbit pulmonary arteries. Bull Exp Biol Med 132:731–733PubMedCrossRefGoogle Scholar
  26. 26.
    Kilger E, Weis F, Briegel J, Frey L, Goetz AE, Reuter D, Nagy A, Schuetz A, Lamm P, Knoll A, Peter K (2003) Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med 31:1068–1074PubMedCrossRefGoogle Scholar
  27. 27.
    Marsden PA, Ballermann BJ (1990) Tumor necrosis factor alpha activates soluble guanylate cyclase in bovine glomerular mesangial cells via an l-arginine-dependent mechanism. J Exp Med 172:1843–1852PubMedCrossRefGoogle Scholar
  28. 28.
    Massoudy P, Mempel T, Raschke P, Becker BF (1999) Reduction of oxygen delivery during post-ischemic reperfusion protects the isolated guinea pig heart. Basic Res Cardiol 94:231–237PubMedCrossRefGoogle Scholar
  29. 29.
    Matsuki T, Beach JM, Klindt RL, Duling BR (1993) Modification of vascular reactivity by alteration of intimal permeability: effect of TNF-alpha. Am J Physiol 264:H1847–H1853PubMedGoogle Scholar
  30. 30.
    Matsuki T, Duling BR (2000) TNF-alpha modulates arteriolar reactivity secondary to a change in intimal permeability. Microcirculation 7:411–418PubMedCrossRefGoogle Scholar
  31. 31.
    Mulivor AW, Lipowsky HH (2002) Role of glycocalyx in leukocyte-endothelial cell adhesion. Am J Physiol Heart Circ Physiol 283:H1282–H1291PubMedGoogle Scholar
  32. 32.
    Mulivor AW, Lipowsky HH (2004) Inflammation- and ischemia-induced shedding of venular glycocalyx. Am J Physiol Heart Circ Physiol 286:H1672–H1680PubMedCrossRefGoogle Scholar
  33. 33.
    Nieuwdorp M, van Haeften TW, Gouverneur MC, Mooij HL, van Lieshout MH, Levi M, Meijers JC, Holleman F, Hoekstra JB, Vink H, Kastelein JJ, Stroes ES (2006) Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 55:480–486PubMedCrossRefGoogle Scholar
  34. 34.
    Okajima K, Uchiba M (1998) The anti-inflammatory properties of antithrombin III: new therapeutic implications. Semin Thromb Hemost 24:27–32PubMedCrossRefGoogle Scholar
  35. 35.
    Pejler G, Abrink M, Ringvall M, Wernersson S (2007) Mast cell proteases. Adv Immunol 95:167–255PubMedCrossRefGoogle Scholar
  36. 36.
    Picchi A, Gao X, Belmadani S, Potter BJ, Focardi M, Chilian WM, Zhang C (2006) Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ Res 99:69–77PubMedCrossRefGoogle Scholar
  37. 37.
    Pries AR, Kuebler WM (2006) Normal endothelium. Handb Exp Pharmacol 1:1–40CrossRefGoogle Scholar
  38. 38.
    Pries AR, Secomb TW, Gaehtgens P (2000) The endothelial surface layer. Pflugers Arch 440:653–666PubMedCrossRefGoogle Scholar
  39. 39.
    Rehm M, Bruegger D, Christ F, Thiel M, Conzen P, Jacob M, Chappell D, Stoeckelhuber M, Welsch U, Reichart B, Peter K, Becker BF (2007) Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 116:1896–1906Google Scholar
  40. 40.
    Rehm M, Zahler S, Lotsch M, Welsch U, Conzen P, Jacob M, Becker BF (2004) Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology 100:1211–1223PubMedCrossRefGoogle Scholar
  41. 41.
    Roemisch J, Gray E, Hoffmann JN, Wiedermann CJ (2002) Antithrombin: a new look at the actions of a serine protease inhibitor. Blood Coagul Fibrinolysis 13:657–670PubMedCrossRefGoogle Scholar
  42. 42.
    Sakata Y, Chancey AL, Divakaran VG, Sekiguchi K, Sivasubramanian N, Mann DL (2008) Transforming growth factor-beta receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor. Basic Res Cardiol 103:60–68PubMedCrossRefGoogle Scholar
  43. 43.
    Sanderson RD, Yang Y, Kelly T, MacLeod V, Dai Y, Theus A (2005) Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies. J Cell Biochem 96:897–905PubMedCrossRefGoogle Scholar
  44. 44.
    Skyschally A, Gres P, Hoffmann S, Haude M, Erbel R, Schulz R, Heusch G (2007) Bidirectional role of tumor necrosis factor-alpha in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction. Circ Res 100:140–146PubMedCrossRefGoogle Scholar
  45. 45.
    Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH, Payen D, Briegel J (2008) Hydrocortisone therapy for patients with septic shock. N Engl J Med 358:111–124PubMedCrossRefGoogle Scholar
  46. 46.
    Thielmann M, Dorge H, Martin C, Belosjorow S, Schwanke U, van de Sand A, Konietzka I, Buchert A, Kruger A, Schulz R, Heusch G (2002) Myocardial dysfunction with coronary microembolization: signal transduction through a sequence of nitric oxide, tumor necrosis factor-alpha, and sphingosine. Circ Res 90:807–813Google Scholar
  47. 47.
    Underwood JL, Murphy CG, Chen J, Franse-Carman L, Wood I, Epstein DL, Alvarado JA (1999) Glucocorticoids regulate transendothelial fluid flow resistance and formation of intercellular junctions. Am J Physiol 277:C330–C342PubMedGoogle Scholar
  48. 48.
    van den Berg BM, Vink H, Spaan JA (2003) The endothelial glycocalyx protects against myocardial edema. Circ Res 92:592–594PubMedCrossRefGoogle Scholar
  49. 49.
    Vink H, Constantinescu AA, Spaan JA (2000) Oxidized lipoproteins degrade the endothelial surface layer: implications for platelet-endothelial cell adhesion. Circulation 101:1500–1502PubMedGoogle Scholar
  50. 50.
    Vogel J, Sperandio M, Pries AR, Linderkamp O, Gaehtgens P, Kuschinsky W (2000) Influence of the endothelial glycocalyx on cerebral blood flow in mice. J Cereb Blood Flow Metab 20:1571–1578PubMedCrossRefGoogle Scholar
  51. 51.
    Westermann D, Van LS, Dhayat S, Dhayat N, Schmidt A, Noutsias M, Song XY, Spillmann F, Riad A, Schultheiss HP, Tschope C (2007) Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol 102:500–507PubMedCrossRefGoogle Scholar
  52. 52.
    Yang S, Zhang L (2004) Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol 2:1–12PubMedCrossRefGoogle Scholar
  53. 53.
    Zahler S, Heindl B, Becker BF (2002) Selectin-mediated rolling of neutrophils is essential for their activation and retention in the reperfused coronary system. Basic Res Cardiol 97:359–364PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2008

Authors and Affiliations

  • Daniel Chappell
    • 1
    • 2
  • Klaus Hofmann-Kiefer
    • 1
  • Matthias Jacob
    • 1
    • 2
  • Markus Rehm
    • 1
  • Josef Briegel
    • 1
  • Ulrich Welsch
    • 3
  • Peter Conzen
    • 1
  • Bernhard F. Becker
    • 2
  1. 1.Clinic of AnaesthesiologyLudwig-Maximilians UniversityMunichGermany
  2. 2.Walter-Brendel Centre of Experimental MedicineLudwig-Maximilians UniversityMunichGermany
  3. 3.Institute of AnatomyLudwig-Maximilians UniversityMunichGermany

Personalised recommendations